Vivesto AB ADR OASMY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.00–0.05
- Bid/Ask
- $0.08 / $0.40
- Market Cap
- $8.95 Mil
- Volume/Avg
- 1,700 / 429
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 14
- Website
- https://www.vivesto.com
Valuation
|
Metric
|
OASMY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.45 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
OASMY
Financial Strength
|
Metric
|
OASMY
|
|---|---|
Quick Ratio | 3.46 |
Current Ratio | 3.51 |
Interest Coverage | — |
Quick Ratio
OASMY
Profitability
|
Metric
|
OASMY
|
|---|---|
Return on Assets (Normalized) | −77.98% |
Return on Equity (Normalized) | −84.16% |
Return on Invested Capital (Normalized) | −82.34% |
Return on Assets
OASMY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Mrlfmsjyrh | Sxvz | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Hwjgfhdl | Jbqqq | $79.0 Bil | |
HLN
| Haleon PLC ADR | Ylhyntj | Tqcm | $38.5 Bil | |
VTRS
| Viatris Inc | Rynwfgshm | Jtk | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cxzsrby | Yst | $11.7 Bil | |
CTLT
| Catalent Inc | Vkjhfxnj | Lfdlny | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Zdwfyrrfl | Vsncw | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Bfzlzhwrn | Snqz | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xqzcznw | Smxwx | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Htgtpygtn | Hrrt | $3.1 Bil |